Earlier Detection and Treatment of Advanced Heart Failure

Even with improving expected survival rates, the five-year mortality rate for heart failure remains very high at nearly 50%.

In this presentation, Dr. Eman Hamad, Director, Advanced Heart Failure and Transplant Program at Temple University Hospital, shares best practice approaches to physician collaboration for better patient outcomes. 

Dr. Hamad discusses:  

  • Key clinical and lab indicators to identify at-risk patients, earlier
  • Insight to the significant degree to which Advanced Heart Failure (AHF) is under-recognized in the medical community
  • Best practices for referral for advanced therapies, with an emphasis on earlier referral to start preventative treatment
  • The importance of shared decision making and giving patients adequate time to accept AHF treatments
  • The treatments available for AHF patients, including medications, cardiac rehab, BiV Pacers, CardioMEMS, VADs, etc., and how a combination of such options can improve AHF patient survival rates and quality-of-life

Created by

Temple Health


Eman A. Hamad, MD

Eman A. Hamad, MD

Director, Advanced Heart Failure & Transplant Program
Director, Cardio-Oncology Program
Medical Director, Mechanical Circulatory Support Program
Temple University Hospital

View full profile